Register: Webinar on Firebrick Half-Year Results and 2025 Plans

  20 Feb 2025

Firebrick Pharma Limited (ASX:FRE) (Firebrick, Company) is pleased to announce that there will be an investor webinar on Tuesday, 25 February 2025 at 12pm (AEDT) / 9am (AWST).

Executive Chairman and Co-Founder, Dr Peter Molloy, will be joined by Tim Sylvester from The Market Link to discuss the Company’s Half Year results, its recent launch of Nasodine Nasal Spray into Fiji and South Pacific, and the Company’s plans for the remainder of 2025. The webinar will provide an important opportunity for shareholders and potential investors to receive an update on the Company’s future plans and activities, and to ask questions via a Q&A segment following the discussion.

Investors are encouraged to attend and to register for the webinar using the following link:

https://us02web.zoom.us/webinar/register/WN_kMH2Lft3QXKgrhlSGEOhEg#/registration